8-methoxy-1-methyl-5-(4-nitrobenzyl)-4-oxo-3,4-dihydro-5H-pyridazino[4,5-b]indole

ID: ALA2088672

PubChem CID: 70684879

Max Phase: Preclinical

Molecular Formula: C19H16N4O4

Molecular Weight: 364.36

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1ccc2c(c1)c1c(C)n[nH]c(=O)c1n2Cc1ccc([N+](=O)[O-])cc1

Standard InChI:  InChI=1S/C19H16N4O4/c1-11-17-15-9-14(27-2)7-8-16(15)22(18(17)19(24)21-20-11)10-12-3-5-13(6-4-12)23(25)26/h3-9H,10H2,1-2H3,(H,21,24)

Standard InChI Key:  XJJLKQCURPTAPU-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 27 30  0  0  0  0  0  0  0  0999 V2000
   -4.0542  -24.6953    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.0554  -25.5224    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3407  -25.9351    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3425  -24.2827    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6275  -24.6917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6272  -25.5224    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8369  -25.7781    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8374  -24.4348    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3519  -25.1079    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5282  -25.0233    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1889  -24.2661    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6796  -23.5928    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5015  -23.6809    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0451  -25.6916    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9868  -23.0141    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4274  -26.4939    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8426  -27.2065    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6654  -27.2000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0806  -27.9117    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6710  -28.6286    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8420  -28.6292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4307  -27.9169    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.7685  -24.2831    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -5.4825  -24.6957    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0867  -29.3440    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6762  -30.0593    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9114  -29.3418    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
 12 13  2  0
 13  8  1  0
  3  6  2  0
 10 14  2  0
  6  7  1  0
 13 15  1  0
  7  9  1  0
  7 16  1  0
  8  5  1  0
 16 17  1  0
  1  2  2  0
 17 18  2  0
  5  4  2  0
 18 19  1  0
  8  9  2  0
 19 20  2  0
  4  1  1  0
 20 21  1  0
  9 10  1  0
 21 22  2  0
 22 17  1  0
  5  6  1  0
  1 23  1  0
 10 11  1  0
 23 24  1  0
 11 12  1  0
  2  3  1  0
 25 26  2  0
 25 27  1  0
 20 25  1  0
M  CHG  2  25   1  27  -1
M  END

Associated Targets(Human)

NCI-H727 (447 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CDK5 Tchem Cyclin-dependent kinase 5/CDK5 activator 1 (3697 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PIK3R1 Tchem PI3-kinase p110-alpha/p85-alpha (2589 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PIK3CA Tclin PI3-kinase p110-alpha subunit (12269 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Huh-7 (12904 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Caco-2 (12174 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDA-MB-231 (73002 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCT-116 (91556 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PC-3 (62116 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Dyrk1a Dual specificity tyrosine-phosphorylation-regulated kinase 1A (1629 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 364.36Molecular Weight (Monoisotopic): 364.1172AlogP: 3.15#Rotatable Bonds: 4
Polar Surface Area: 103.05Molecular Species: NEUTRALHBA: 6HBD: 1
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 10.73CX Basic pKa: CX LogP: 2.58CX LogD: 2.58
Aromatic Rings: 4Heavy Atoms: 27QED Weighted: 0.44Np Likeness Score: -1.33

References

1. Bruel A, Logé C, Tauzia ML, Ravache M, Le Guevel R, Guillouzo C, Lohier JF, Oliveira Santos JS, Lozach O, Meijer L, Ruchaud S, Bénédetti H, Robert JM..  (2012)  Synthesis and biological evaluation of new 5-benzylated 4-oxo-3,4-dihydro-5H-pyridazino[4,5-b]indoles as PI3Kα inhibitors.,  57  [PMID:23063566] [10.1016/j.ejmech.2012.09.001]

Source